Copy number variation in Parkinson's disease. [Genome Med. 2010] - PubMed result

Genome Med. 2010 Sep 6;2(9):62. [Epub ahead of print]

Copy number variation in Parkinson's disease.
Toft M, Ross OA.

Department of Neuroscience, Mayo Clinic Jacksonville, 4500 San Pablo Road South, Jacksonville, FL 32224, USA. ross.owen@mayo.edu.

Abstract
ABSTRACT: A central theme of human genetic studies is to understand genomic variation and how this underlies the inherited basis of disease. Genomic variation can provide increased biological understanding of disease processes, which is necessary to develop future treatments. Recent technological advances have highlighted the role of copy number variants in normal and pathological phenotypic expression. These applications have been used in studies of Parkinson's disease, a common, late-onset, progressive neurodegenerative disorder. At present the main therapeutic approach is administration of symptom-alleviating drugs, which neither reverses the disease process nor halts its progression. However, the generation of in vivo model systems and development of novel disease intervention strategies for Parkinson's disease have come from research on monogenic forms of the disorder, including those caused by copy number variants. Here, we review the role of copy number variants and the mechanistic insights they have provided on the pathogenesis of Parkinson's disease.

PMID: 20828427 [PubMed - as supplied by publisher]
Copy number variation in Parkinson's disease. [Genome Med. 2010] - PubMed result